The same research group later, in a separate study, identified and characterized the small molecule Ro 08-2750 (Ro) as an inhibitor targeting the Musashi (MSI) family of RBPs, particularly MSI2, in the context of acute myeloid leukemia (AML). The gene discussed is MSI2; the disease is acute myeloid leukemia.